Generative AI can be used to combat misinformation. However, it can also exacerbate the problem by producing convincing ...

Actigraphy data show irregular sleep-wake rhythms nearly double the risk for relapse in individuals with remitted major depressive disorder.

Travere Therapeutics, Inc. (NASDAQ: TVTX) today reported its fourth quarter and full year 2025 financial results and provided a corporate update.

Novo Nordisk advanced coramitug into the Phase III CLEOPATTRA trial, evaluating 1,280 patients with amyloid transthyretin cardiomyopathy or ATTR-CM. This decision was informed by results from their ...

Could a smart watch act as an early-warning system for depression relapse? New research from McMaster University suggests ...

Complete relief pitcher rankings with 2026 projections and player-by-player analysis.

What if the United States isn’t ending wars, just interrupting them? Since returning to the White House, President Donald ...

Could a smart watch act as an early‑warning system for depression relapse? New research from McMaster University suggests ...

Chinese NMPA approves Bayer’s oral ARi Nubeqa in combo with ADT for use in patients with metastatic hormone-sensitive prostate cancer: Berlin Wednesday, February 4, 2026, 14:00 ...

Maternal mortality remains disproportionately high in low-income and middle-income countries, where pyramidal health systems ...

FDA feedback focused on dosing and testing questions, not safety or effectiveness concerns. ・Joenja’s existing approval and sales in patients aged 12 and older remain unchanged. ・Pharming said it ...

Generative AI is now the number one type of AI solution deployed in organizations, from SMBs to global enterprises, according to Gartner. In a recent poll, they found that 40% of respondents said ...